Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00283153 · ClinicalTrials.gov registry record · Phase 2
Affect Recognition: Enhancing Performance of Persons With Acquired Brain Injury (ABI)
A Phase 2 study of Acquired Brain Injury (Including Stroke), sponsored by University at Buffalo.
- Completed
- Registry status
- Phase 2
- Development phase
- 71
- Enrollment target
- 4
- Study locations
NCT00283153: Completed Phase 2 study of Acquired Brain Injury (Including Stroke), sponsored by University at Buffalo.
NCT00283153 is a Phase 2 study of Acquired Brain Injury (Including Stroke) that has completed, run by University at Buffalo. The registered enrollment target is 71 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00283153, a Phase 2 study of Acquired Brain Injury (Including Stroke), has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 71 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this research is to evaluate the effectiveness of three training programs designed to teach persons with acquired brain injury (ABI) to recognize emotions. It is hypothesized that the training programs will enhance several aspects of emotion recognition in persons with ABI. Furthermore, it is expected that these effects will be maintained over time, and will positively influence participants' social behavior and integration.
Conditions Studied
Interventions
- BEHAVIORAL Facial Affect Recognition Training
- OTHER Stories of Emotional Inference
Study Locations (4)
New York
- University at Buffalo - Buffalo
North Carolina
- Carolinas HealthCare System - Charlotte
Ontario
- Brock University - St. Catharines
Other
- Massey University - Wellington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2008-10 |
| Est. Completion | 2014-08 |
| Phase | Phase 2 |
What the finished NCT00283153 record still lists
NCT00283153 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Acquired Brain Injury (Including Stroke) appearing as the primary indexed condition, and to 2 interventions - of which Facial Affect Recognition Training is the first listed.
NCT00283153 reports a single indexed study location in New York, North Carolina, Ontario.
Frequently Asked Questions
What is clinical trial NCT00283153 about?
NCT00283153 is a clinical study titled "Affect Recognition: Enhancing Performance of Persons With Acquired Brain Injury (ABI)". The purpose of this research is to evaluate the effectiveness of three training programs designed to teach persons with acquired brain injury (ABI) to recognize emotions. It is hypothesized that the training programs will enhance several aspects of emotion recognition in persons with ABI. Furthermor...
What is the current status of trial NCT00283153?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 71 participants. The study started on 2008-10. Estimated completion is 2014-08.
What conditions does trial NCT00283153 study?
This clinical trial studies the following conditions: Acquired Brain Injury (Including Stroke).
What interventions are being tested in trial NCT00283153?
The interventions under investigation include: Facial Affect Recognition Training (BEHAVIORAL), Stories of Emotional Inference (OTHER).
Who is sponsoring clinical trial NCT00283153?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00283153 being conducted?
This trial has 4 study locations across New York, North Carolina, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00283153's enrollment target sits among peer trials
71 936th of 2000 higher than 1,064 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia